• Publications
  • Influence
Criteria for the diagnosis of corticobasal degeneration
Current criteria for the clinical diagnosis of pathologically confirmed corticobasal degeneration (CBD) no longer reflect the expanding understanding of this disease and its clinicopathologicExpand
  • 812
  • 57
  • PDF
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
BACKGROUND Parkinson disease (PD) is a degenerative neurological disorder for which no treatment has been shown to slow the progression. OBJECTIVE To determine whether a range of dosages ofExpand
  • 903
  • 29
  • PDF
The clinically important difference on the unified Parkinson's disease rating scale.
OBJECTIVE To determine the estimates of minimal, moderate, and large clinically important differences (CIDs) for the Unified Parkinson's Disease Rating Scale (UPDRS). DESIGN Cross-sectionalExpand
  • 300
  • 24
  • PDF
Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease.
OBJECTIVE To compare the efficacy of treadmill exercises and stretching and resistance exercises in improving gait speed, strength, and fitness for patients with Parkinson disease. DESIGN AExpand
  • 242
  • 20
  • PDF
Natural history of multiple system atrophy in the USA
  • 123
  • 15
The use of alternative therapies by patients with Parkinson’s disease
Objective: To determine the prevalence and spectrum of use of alternative therapy (AT) by patients with PD and to determine whether use of AT correlates with demographic, social, or disease-specificExpand
  • 158
  • 12
Causative factors and epidemiology of bilateral vestibulopathy in 255 patients
In their study of bilateral vestibulopathy, Zingler and colleagues employed standard bedside tests to screen for hearing loss: asking patients whether they had impaired hearing and whispered speech.Expand
  • 127
  • 11
The evolution of disability in Parkinson disease
The objectives of this study are to assess the level of disease severity associated with disability in Parkinson disease (PD) and the sequence of loss of independence in basic and instrumentalExpand
  • 192
  • 10
Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia.
BACKGROUND Mutations in the tau gene have been reported in families with frontotemporal dementia (FTD) linked to chromosome 17. It remains uncertain how commonly such mutations are found in patientsExpand
  • 160
  • 9
  • PDF
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
To evaluate the efficacy and safety of donepezil, an acetylcholinesterase inhibitor, as a treatment for cognitive impairment and dementia in patients with Parkinson' s disease (PD).
  • 217
  • 8